Neurology 2002-04-23

Increased levels of the pro-inflammatory prostaglandin PGE2 in CSF from ALS patients.

G Almer, P Teismann, Z Stevic, J Halaschek-Wiener, L Deecke, V Kostic, S Przedborski

Index: Neurology 58(8) , 1277-9, (2002)

Full Text: HTML

Abstract

Levels of the potent pro-inflammatory prostaglandin E(2) (PGE(2)) are elevated in postmortem spinal cords from patients with ALS, and inhibition of a key PGE(2)-synthesizing enzyme, cylcooxygenase-2, is neuroprotective in an in vitro model of ALS. The authors report that 82% of the patients with ALS studied had 2 to 10 times higher PGE(2) levels in CSF compared with normal control subjects. That affected areas of the CNS are inflamed in ALS supports this. CSF PGE(2) measurement may be useful in monitoring treatment for ALS.

Related Compounds

  • Dinoprostone
  • thyronine

Related Articles:

MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis.

2015-03-01

[Br. J. Pharmacol. 172(5) , 1222-36, (2015)]

Isothiocyanate analogs targeting CD44 receptor as an effective strategy against colon cancer.

2014-07-01

[Med. Chem. Res. 23(8) , 3836-3851, (2014)]

Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions.

2014-11-01

[Cytotherapy 16(11) , 1486-500, (2014)]

HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration.

2015-06-01

[Br. J. Pharmacol. 172 , 3028-42, (2015)]

Kaposi's sarcoma-associated herpesvirus induces Nrf2 activation in latently infected endothelial cells through SQSTM1 phosphorylation and interaction with polyubiquitinated Keap1.

2015-02-01

[J. Virol. 89(4) , 2268-86, (2015)]

More Articles...